OIS@ASCRS

InnFocus Targeting Trabeculectomy

By Mario Admin | May 20, 2016

InnFocus’ MicroShunt is the only micro-invasive glaucoma surgery (MIGS) device undergoing a randomized clinical trial that uses trabeculectomy as the comparator. “We want to get…

Read More

ClarVista Medical HARMONI Offers “Elegant Simplicity”

By Mario Admin | May 20, 2016

ClarVista Medical is a clinical-stage ophthalmic company that is introducing the HARMONI Modular IOL system to help surgeons navigate “the increasingly demanding environment of cataract…

Read More

Yeu on the Success of the Spotlight on the Premium Channel

By Mario Admin | May 20, 2016

Elizabeth Yeu, MD, led the “Spotlight on the Premium Channel” discussion at OIS@ASCRS 2016. In her session, representatives from AcuFocus, Bausch + Lomb, Abbott Medical…

Read More

Thompson Sees Huge Influx of New Refractive Tech

By Mario Admin | May 19, 2016

Vance Thompson, MD is an internationally recognized specialist in Laser Vision Correction and Advanced Cataract Surgery. As a leading international researcher he has played a…

Read More

Ivantis Goes After Canal-based MIGS

By Mario Admin | May 19, 2016

Ivantis was founded in 2007 by two coronary stent inventors to develop “the only minimally invasive microstent for glaucoma that dilates and scaffolds Schlemm’s canal.”…

Read More

Encore Vision Reports Positive Phase I/II Results

By Mario Admin | May 19, 2016

Results from a Phase I/Phase II study of EV06 ophthalmic solution for the treatment of presbyopia show “it works to restore bilateral near vision. It…

Read More

ReVision Optics Eyes Panel Discussion in Q3

By Mario Admin | May 18, 2016

The Raindrop Near Vision Inlay for the treatment of presbyopia boasts a 2-mm diameter, 80% water composition, the same refractive index as the natural cornea,…

Read More

Transcend Medical

By Mario Admin | May 18, 2016
Read More

From Mythbuster to Dealmaker

By Mario Admin | May 18, 2016

Barry Cheskin, CEO, president and co-founder of PowerVision, provides details on his company’s new partnership with Alcon. Video Highlights: 00:30 – Details on Alcon deal…

Read More
OIS@ASCRS - Companies To Watch - LensGen (2016)

LensGen

By Tom Salemi | May 18, 2016

LensGen is a clinical stage company developing an accommodating IOL (AIOL) that mimics the natural human lens and uses the eye’s natural accommodative mechanism to…

Read More
OIS@ASCRS - Companies to Watch - Allotex 2016

Allotex

By Mario Admin | May 18, 2016

The driving force behind Allotex was the observation that the potential interest in synthetic corneal inlay technology was being dampened by the persistent biocompatibility issue.…

Read More

Allergan Sees MIGS as “Ready to Explode”

By Mario Admin | May 17, 2016

Allergan purchased AqueSys (developer of the Xen Gel Stent) in a $20 million deal earlier this year. “Just a few years ago, the energy and…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.